Loading...
•
Sep 30, 2023
Ekso Bionics Q3 2023 Earnings Report
Ekso Bionics reported a 38% year-over-year revenue increase and achieved a record quarter of EVO unit sales.
Key Takeaways
Ekso Bionics reported a strong third quarter with a 38% increase in revenue, reaching $4.6 million, driven by solid sales of EksoHealth devices and a record number of EVO unit sales. The company's gross profit also increased by 46% to $2.5 million, with a gross margin of approximately 53%.
Reported revenue of $4.6 million in Q3 2023, a 38% increase year-over-year.
Sold a total of 41 EksoHealth devices in Q3 2023.
Achieved a record quarter of EVO unit sales.
Gross profit of $2.5 million in Q3 2023, compared to $1.7 million in the same period last year.
Forward Guidance
Ekso Bionics anticipates potential market expansion for home and community devices for spinal cord injury patients, pending CMS rule changes and application approval.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...